- cross-posted to:
- news@lemmy.world
- technology@lemmy.world
- cross-posted to:
- news@lemmy.world
- technology@lemmy.world
Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.
Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.
Sorry, I pressed reply in Voyager, but it ended up as a comment to my post instead of a reply to your comment.